Abstract:3208 Myelodysplastic syndrome(MDS) is a group of monoclonal hematopoietic stem cell disorders characterized by ineffective hematopoiesis and peripheral blood cytopenias. The clinical course of the disease and response to therapy vary considerably among individuals, therefore no single agent is expected to benefit all MDS patients universally. Recently arsenic trioxide (As2O3) was used to treat patients with MDS. To determine the effection of arsenic trioxide on MDS, MUTZ-1 cell line which was isolated from the peripheral blood of a MDS-RAEB patient, was treated by 0.5–8μmol/l As2O3. The inhibition of cell growth was detected by MTT assay. Apoptosis was assessed by morphology, DNA ladder, and the apoptotic peak before G1 phase cells by flow cytometry. The results revealed that As2O3 inhibited MUTZ-1 cell growth with IC50 of 5.7μmol/l, 1.87μmol/l, 0.91μmol/l when treated after 24h,48h and 72h respectively. As2O3 induces apoptosis in MUTZ-1 cells in a dose- and time-dependent manner. 2.0μmol/l is an effective concentration in the action of As2O3 induces apoptosis in MUTZ-1cells. Caspase protease family is a group of key apoptosis regulatory molecule that becomes activated during the early stages of apoptosis. We demonstrated that in the process of apoptosis of MUTZ-1 cells induced by As2O3, some members of the caspase protease family include caspase-8, caspase-3 and its substrate PARP were activated. It means that the activation of caspase protease is an important way in the apoptosis of MUTZ-1 cells induced by As2O3. In addition to the activation of caspase protease, we detected the expression of hTERT mRNA by RT-PCR meanwhile. We found that the expression of hTERT mRNA was down regulated by 2–8μmol/l As2O3 in MUTZ-1cells. We concluded that As2O3 should be an effective agent in the treatment of MDS. It induces apoptosis in MDS cell line MUTZ-1 cells in vitro via the activation of caspases and down-regulation of hTERT mRNA expression. No significant financial relationships to disclose.

[Inhibition Effect of Gambogic Acid on MUTZ-1 Cell Line and Its Possible Mechanism].

Effect of 5-Aza-2′-deoxycytidine in High-Risk Myelodysplasia Cells in Vitro.

[Study of Triptolide-Induced Apoptosis in MUTZ-1 Cells and Its Allied Mechanism].

[Inhibition Effect of Arsenic Trioxide on the Growth of Human MDS Cell Line MUTZ-1 Cells].

[Effect of gambogic acid on proliferation of SKM-1 cells and its mechanism].

Arsenic Trioxide Induces Apoptosis in MDS Cell Line MUTZ-1 Cells Via Caspase-Dependent Pathways and Down Regulation of Htert

[Inhibition Effect of Topotecan on Human Myelodysplastic Syndrome Cells in Vitro and in Vivo].

EFFECTS OF GAMBOGIC ACID ON THE PROLIFERATION AND CELL APOPTOSIS OF CELL LINE NCI-H929 IN MULTIPLE MYELOMA

Effect of Gambogic Acid on the Proliferation of Human Colon Carcinoma Cell SW480 and the Expression of VEGFR2

Suppression of APC Production During Apoptosis of Human Colorectal Cancer Cell Line SW480 Induced by Gambogic Acid

The tubulin polymerization inhibitor gambogenic acid induces myelodysplastic syndrome cell apoptosis through upregulation of Fas expression mediated by the NF-κB signaling pathway

Synergistic Anti-Proliferative Effects of Gambogic Acid with Docetaxel in Gastrointestinal Cancer Cell Lines

Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro

Gambogenic acid induction of apoptosis in a breast cancer cell line.

Antitumor Activity and Drug Interactions of Proteasome Inhibitor Bortezomib in Human High-Risk Myelodysplastic Syndrome Cells.

Gambogenic Acid Exerts Antitumor Activity in Hypoxic Multiple Myeloma Cells by Regulation of Mir-21

Anti-proliferative and Apoptotic Effects of S1, a Tetrandrine Derivative, in Human Gastric Cancer BGC-823 Cells

Gambogenic Acid Synergistically Potentiates Bortezomib-Induced Apoptosis in Multiple Myeloma

The Study Of Effect And Mechanism By Vitamin K2 On Human Mds Cell Line Mutz-1.

Gambogic Acid Induces Mitochondria-Dependent Apoptosis by Modulation of Bcl-2 and Bax in Mantle Cell Lymphoma JeKo-1 Cells.

Enhancement of anticancer efficacy of chemotherapeutics by gambogic acid against gastric cancer cells.